Jignesh D Dalal MD
Professor, Pediatrics, Case Western Reserve University,Cleveland Ohio. Director Pediatric BMT
Join to View Full Profile
2401 Gillham RdKansas City, MO 64108
Phone+1 816-234-3000
Fax+1 216-767-8778
Dr. Dalal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Jignesh Dalal is a pediatric hematologist and oncologist based in Kansas City, MO. He completed his fellowship in Pediatric Hematology/Oncology at Johns Hopkins University and his pediatric residency at Stony Brook Medicine/University Hospital. As an MD at Rainbow, he has contributed to several notable publications in the field of leukemia and hematopoietic stem cell transplantation, and has been involved in a variety of clinical trials focusing on sickle cell disease, neuroblastoma, and stem cell transplantation. Dr. Dalal was recognized as a Regional Top Doctor by Castle Connolly in 2014.
Education & Training
Johns Hopkins UniversityFellowship, Pediatric Hematology/Oncology, 1998 - 2001
Stony Brook Medicine/University HospitalResidency, Pediatrics, 1995 - 1998
N.H.L Municipal Medical CollegeClass of 1986
Certifications & Licensure
OH State Medical License 2015 - 2027
MO State Medical License 2002 - 2026
TX State Medical License 2002 - 2006
MD State Medical License 1999 - 2002
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- Single vs Double Umbilical Cord Blood Transplants in Children With High Risk Leukemia and Myelodysplasia (BMT CTN 0501) Start of enrollment: 2006 Dec 01
- Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases
- Stem Cell Related Donor Safety Study Start of enrollment: 2010 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- PTCy-ATG mutually exclusive or additive? Anti-thymocyte globulin combined with post-transplantation cyclophosphamide reduce graft-versus-host disease in hematopoietic ...Prarthana Dalal, Jignesh Dalal
Leukemia & Lymphoma. 2024-12-01 - 12 citationsProspective PTCTC trial of myeloablative haplo-BMT with posttransplant cyclophosphamide for pediatric acute leukemias.Juan C Fierro-Pineda, Hua-Ling Tsai, Amanda Blackford, Andrew Cluster, Emi Caywood
Blood Advances. 2023-09-26 - Editorial: Advances in the treatment of chronic myeloid leukemia.Ahmet Emre Eşkazan, Chung H Kok, David Yeung, Jignesh Dalal, Mario Tiribelli
Frontiers in Oncology. 2023-01-01
Abstracts/Posters
- Increased Toxicity Among Adolescents and Young Adults Treated for Acute Myeloid Leukemia at US Children's HospitalsJignesh Dalal, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Preemptive Administration of Ruxolitinib Rapidly Ameliorate Gvhd after Allo-Hematopoietic Stem Cell Transplantation: A Single-Center Retrospective StudyJignesh Dalal, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Cathelicidin Antimicrobial Peptide Expression Is Inversely Associated with Absolute Neutrophil Counts in Pediatric HCT RecipientsJignesh Dalal, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Press Mentions
- University Hospitals Doctor Conducting Clinical Trial for Sickle Cell DiseaseNovember 5th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
